The Lancet Haematology · 2019 · 138 citations · 27 references
MedicineHematologyOncologyChemotherapyClinical PharmacologyHematologic OncologyChemotherapy In Hematologic MalignanciesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyHematologic ToxicityHematologic Toxicity ManagementMyelodysplastic SyndromesAcute LeukemiasAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentCytarabine-based RegimensMyelodysplastic Syndrome TherapyMyelodysplastic Syndrome TreatmentTherapy-related Myelodysplastic Syndromes
27
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang, Michael A. Postow, Robert J. Orlowski et al. · Nature · 2017 · 1.7K citations · Full text
Life Sciences, Immunology, Oncology +16
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Liran I. Shlush, Sasan Zandi, Amanda Mitchell et al. · Nature · 2014 · 1.4K citations · Full text
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Alice O. Kamphorst, Andreas Wieland, Tahseen H. Nasti et al. · Science · 2017 · 1K citations · Full text
Life Sciences, Immunology, Oncology +16